Goldman Sachs’s Intermolecular, Inc. IMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-331,035
| Closed | -$387K | – | 5517 |
|
|
2019
Q2 | $387K | Buy |
+331,035
| New | +$380K | ﹤0.01% | 4499 |
|
|
2017
Q1 | – | Sell |
-11,529
| Closed | -$11K | – | 7140 |
|
|
2016
Q4 | $11K | Sell |
11,529
-17,064
| -60% | -$16.8K | ﹤0.01% | 6750 |
|
|
2016
Q3 | $28K | Sell |
28,593
-4,846
| -14% | -$5.97K | ﹤0.01% | 6665 |
|
|
2016
Q2 | $49K | Buy |
33,439
+18,298
| +121% | +$36.9K | ﹤0.01% | 6435 |
|
|
2016
Q1 | $38K | Sell |
15,141
-18,685
| -55% | -$42.1K | ﹤0.01% | 6546 |
|
|
2015
Q4 | $78K | Sell |
33,826
-28,456
| -46% | -$59.5K | ﹤0.01% | 6310 |
|
|
2015
Q3 | $118K | Buy |
62,282
+38,381
| +161% | +$80.3K | ﹤0.01% | 6387 |
|
|
2015
Q2 | $47K | Buy |
23,901
+4,794
| +25% | +$8.86K | ﹤0.01% | 6884 |
|
|
2015
Q1 | $31K | Sell |
19,107
-12,185
| -39% | -$20.8K | ﹤0.01% | 6825 |
|
|
2014
Q4 | $60K | Buy |
31,292
+4,176
| +15% | +$8.88K | ﹤0.01% | 6756 |
|
|
2014
Q3 | $63K | Buy |
27,116
+11,271
| +71% | +$25.8K | ﹤0.01% | 6765 |
|
|
2014
Q2 | $37K | Sell |
15,845
-4,171
| -21% | -$10.4K | ﹤0.01% | 6808 |
|
|
2014
Q1 | $56K | Sell |
20,016
-530,960
| -96% | -$1.93M | ﹤0.01% | 6540 |
|
|
2013
Q4 | $2.71M | Buy |
550,976
+3,924
| +0.7% | +$22.2K | ﹤0.01% | 3757 |
|
|
2013
Q3 | $3.01M | Sell |
547,052
-312,547
| -36% | -$1.96M | ﹤0.01% | 3494 |
|
|
2013
Q2 | $6.25M | Buy |
+859,599
| New | +$7.32M | ﹤0.01% | 2516 |
|
Goldman Sachs's IMI Position: Q3 2019 in Review
Goldman Sachs sold out of Intermolecular, Inc. (IMI) in Q3 2019, closing a stake of 331,035 shares — an estimated $387K sold.
Goldman Sachs first reported a position in IMI in Q2 2013 and held it in 16 quarters. The position peaked at $6.25M in Q2 2013. 0 funds tracked by Wall St. Rank hold IMI as of Q3 2019.
- Goldman Sachs reported no remaining Intermolecular, Inc. position as of Q3 2019 after selling out during the quarter.
- Goldman Sachs sold 331,035 Intermolecular, Inc. shares in Q3 2019, an estimated $387K.
- Goldman Sachs first reported a position in Intermolecular, Inc. in Q2 2013 and held it in 16 quarters.
- Goldman Sachs's Intermolecular, Inc. position peaked at $6.25M in Q2 2013.
- 0 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2019.
Based on Goldman Sachs's 13F filing for Q3 2019, filed 14 Nov 2019.